Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAX125 Phase II in older adults
NCT00966238Phase 2Completed
- Sponsor
- VaxInnate Corporation
- Start
- Sep 2009
- Primary completion
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of VAX125 in influenza, sponsored by VaxInnate Corporation. Started Sep 2009; status: completed.
02
Drugs
VAX125
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00966238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966238.